The obesity epidemic and nonalcoholic fatty liver disease in children

Article

Abstract

Childhood obesity is a worldwide health problem associated with an increase in the prevalence and severity of nonalcoholic fatty liver disease (NAFLD). This review covers the progress made between 2005 and 2007 in understanding the epidemiology, histology, and treatment of pediatric NAFLD. The number of children with NAFLD presents a major public health crisis. Noninvasive diagnostic tools offer future promise, but currently are unable to grade and stage disease. Therefore, pediatric NAFLD remains a clinico-pathological diagnosis requiring direct demonstration of liver steatosis and the exclusion of other causes of fatty liver and/or hepatitis. There are currently no proven therapies for NAFLD in children; however, TONIC (Treatment of Nonalcoholic Fatty Liver Disease in Children), the first multicenter clinical trial of pediatric NAFLD, is currently in progress. Such studies are imperative to address fundamental questions regarding cause and cure.

References and Recommended Reading

  1. 1.
    Ogden CL, Carroll MD, Curtin LR, et al.: Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006, 295:1549–1555.PubMedCrossRefGoogle Scholar
  2. 2.
    Janssen I, Katzmarzyk PT, Boyce WF, et al.: Comparison of overweight and obesity prevalence in school-aged youth from 34 countries and their relationships with physical activity and dietary patterns. Obes Rev 2005, 6:123–132.PubMedCrossRefGoogle Scholar
  3. 3.
    Park HS, Han JH, Choi KM, Kim SM: Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 2005, 82:1046–1051.PubMedGoogle Scholar
  4. 4.
    Muntner P, He J, Cutler JA, et al.: Trends in blood pressure among children and adolescents. JAMA 2004, 291:2107–2113.PubMedCrossRefGoogle Scholar
  5. 5.
    Williams DE, Cadwell BL, Cheng YJ, et al.: Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999–2000. Pediatrics 2005, 116:1122–1126.PubMedCrossRefGoogle Scholar
  6. 6.
    Burgert TS, Taksali SE, Dziura J, et al.: Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006, 91:4287–4294.PubMedCrossRefGoogle Scholar
  7. 7.
    Pacifico L, Celestre M, Anania C, et al.: MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr 2007, 96:542–547.PubMedCrossRefGoogle Scholar
  8. 8.
    Schwimmer JB, Behling C, Newbury R, et al.: Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005, 42:641–649.PubMedCrossRefGoogle Scholar
  9. 9.
    Nobili V, Marcellini M, Devito R, et al.: NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 2006, 44:458–465.PubMedCrossRefGoogle Scholar
  10. 10.
    Xanthakos S, Miles L, Bucuvalas J, et al.: Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Clin Gastroenterol Hepatol 2006, 4:226–232.PubMedCrossRefGoogle Scholar
  11. 11.
    Kleiner DE, Brunt EM, Van Natta M, et al.: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313–1321.PubMedCrossRefGoogle Scholar
  12. 12.
    Riley MR, Bass NM, Rosenthal P, Merriman RB: Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists. J Pediatr 2005, 147:839–842.PubMedCrossRefGoogle Scholar
  13. 13.
    Fishbein M, Mogren J, Mogren C, et al.: Undetected hepatomegaly in obese children by primary care physicians: a pitfall in the diagnosis of pediatric nonalcoholic fatty liver disease. Clin Pediatr (Phila) 2005, 44:135–141.CrossRefGoogle Scholar
  14. 14.
    Schwimmer JB, Deutsch R, Kahen T, et al.: Prevalence of fatty liver in children and adolescents. Pediatrics 2006, 118:1388–1393.PubMedCrossRefGoogle Scholar
  15. 15.
    Nadeau KJ, Klingensmith G, Zeitler P: Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 2005, 41:94–98.PubMedCrossRefGoogle Scholar
  16. 16.
    Radetti G, Kleon W, Stuefer J, Pittschieler K: Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Acta Paediatr 2006, 95:833–837.PubMedCrossRefGoogle Scholar
  17. 17.
    Quiros-Tejeira RE, Rivera CA, Ziba TT, et al.: Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile. J Pediatr Gastroenterol Nutr 2007, 44:228–236.PubMedGoogle Scholar
  18. 18.
    Schwimmer JB, McGreal N, Deutsch R, et al.: Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005, 115:e561–e565.PubMedCrossRefGoogle Scholar
  19. 19.
    Louthan MV, Theriot JA, Zimmerman E, et al.: Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr 2005, 41:426–429.PubMedCrossRefGoogle Scholar
  20. 20.
    Mandato C, Lucariello S, Licenziati MR, et al.: Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr 2005, 147:62–66.PubMedCrossRefGoogle Scholar
  21. 21.
    Sartorio A, Del Col A, Agosti F, et al.: Predictors of nonalcoholic fatty liver disease in obese children. Eur J Clin Nutr 2007, 61:877–883.PubMedCrossRefGoogle Scholar
  22. 22.
    Fishbein MH, Mogren C, Gleason T, Stevens WR: Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2006, 42:83–88.PubMedGoogle Scholar
  23. 23.
    Louthan MV, Barve S, McClain CJ, Joshi-Barve S: Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J Pediatr 2005, 147:835–838.PubMedCrossRefGoogle Scholar
  24. 24.
    Nobili V, Manco M, Ciampalini P, et al.: Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol 2006, 155:735–743.PubMedCrossRefGoogle Scholar
  25. 25.
    Iacobellis A, Marcellini M, Andriulli A, et al.: Noninvasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis. World J Gastroenterol 2006, 12:7821–7825.PubMedGoogle Scholar
  26. 26.
    Manco M, Marcellini M, Giannone G, Nobili V: Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol 2007, 127:954–960.PubMedCrossRefGoogle Scholar
  27. 27.
    de Piano A, Prado WL, Caranti DA, et al.: Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2007, 44:446–452.PubMedCrossRefGoogle Scholar
  28. 28.
    Tock L, Prado WL, Caranti DA, et al.: Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy. Eur J Gastroenterol Hepatol 2006, 18:1241–1245.PubMedCrossRefGoogle Scholar
  29. 29.
    Schwimmer JB, Middleton MS, Deutsch R, Lavine JE: A phase 2 clinical trial of metformin as a treatment for nondiabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2005, 21:871–879.PubMedCrossRefGoogle Scholar
  30. 30.
    Lavine JE, Schwimmer JB: Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr 2006, 42:129–130.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Division of Gastroenterology, Hepatology, and Nutrition, Department of PediatricsUniversity of California, San Diego Medical CenterSan DiegoUSA

Personalised recommendations